A growing U.S. demand for faster, AI-powered tools in cardiopulmonary care is opening up substantial commercial opportunities for Australian medtech company 4DMedical (ASX:4DX). The Melbourne-based imaging innovator has secured a significant contract with Intermountain Health—one of the United States’ largest and most respected health systems—for the rollout of its newly FDA-cleared Pulmonary Hypertension Analysis (PHA™)
Read More
Race Oncology (ASX:RAC) has taken a step towards the development of a new cancer-fighting drug therapy, dosing the first patient in its Phase 1 trial of RC220, a reformulated version of bisantrene, aimed at treating advanced solid tumours. The early-stage trial marks a key milestone for Australia’s biotech sector and positions Race Oncology at the forefront
Read More
The March 2025 quarter CPI data released today were a touch above market expectations. The headline CPI rose by 0.9% over the quarter, well up on the slight 0.2% increase reported in the prior quarter. This delivered an annual CPI increase in the March 2025 quarter of 2.4%, which matched that reported in the prior
Read More
Just 12 months after launching their refurbished tech division, eCommerce company Harris Technology (ASX: HT8) is set to consolidate its position as a leading seller of refurbished tech products in Australia by expanding into new product categories. The expansion opportunity comes after Harris Technology caught the attention of Taiwanese tech giant FSP Technology Inc which
Read More
Australian biotech PYC Therapeutics (ASX:PYC) has taken a major step forward with its lead program, presenting clinical data that signals a significant opportunity in the treatment of genetic eye diseases — a space where no treatments currently exist. The company announced that interim results from its Phase 1/2 trials for VP-001 — a drug candidate
Read More
Australia’s Push To Lead In High Purity Alumina (HPA) Impact Minerals (ASX:IPT) has secured a 50% stake in Alluminous Pty Ltd, which recently acquired the high-potential HiPurA® HPA processing technology. The move is a step in Impact’s strategy to become a vertically integrated HPA producer and could shave years off its path to commercialisation. “This
Read More